Astrazeneca Plc Stock Probability of Future Pink Sheet Price Finishing Over 135.35
| AZNCF Stock | USD 149.25 4.23 2.76% |
AstraZeneca |
AstraZeneca PLC Target Price Odds to finish over 135.35
The tendency of AstraZeneca Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 135.35 in 90 days |
| 149.25 | 90 days | 135.35 | about 40.63 |
Based on a normal probability distribution, the odds of AstraZeneca PLC to stay above $ 135.35 in 90 days from now is about 40.63 (This AstraZeneca PLC probability density function shows the probability of AstraZeneca Pink Sheet to fall within a particular range of prices over 90 days) . Probability of AstraZeneca PLC price to stay between $ 135.35 and its current price of $149.25 at the end of the 90-day period is about 38.6 .
Assuming the 90 days horizon AstraZeneca PLC has a beta of 0.35. This suggests as returns on the market go up, AstraZeneca PLC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AstraZeneca PLC will be expected to be much smaller as well. Additionally AstraZeneca PLC has an alpha of 0.2559, implying that it can generate a 0.26 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). AstraZeneca PLC Price Density |
| Price |
Predictive Modules for AstraZeneca PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AstraZeneca PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AstraZeneca PLC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AstraZeneca PLC is not an exception. The market had few large corrections towards the AstraZeneca PLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AstraZeneca PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AstraZeneca PLC within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.26 | |
β | Beta against NYSE Composite | 0.35 | |
σ | Overall volatility | 7.68 | |
Ir | Information ratio | 0.09 |
AstraZeneca PLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AstraZeneca PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AstraZeneca PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company has accumulated 22.96 B in total debt with debt to equity ratio (D/E) of 0.87, which is about average as compared to similar companies. AstraZeneca PLC has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AstraZeneca PLC until it has trouble settling it off, either with new capital or with free cash flow. So, AstraZeneca PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AstraZeneca PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AstraZeneca to invest in growth at high rates of return. When we think about AstraZeneca PLC's use of debt, we should always consider it together with cash and equity. |
AstraZeneca PLC Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AstraZeneca Pink Sheet often depends not only on the future outlook of the current and potential AstraZeneca PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AstraZeneca PLC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 B | |
| Dividends Paid | -4.4 B | |
| Short Long Term Debt | 5.3 B |
AstraZeneca PLC Technical Analysis
AstraZeneca PLC's future price can be derived by breaking down and analyzing its technical indicators over time. AstraZeneca Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AstraZeneca PLC. In general, you should focus on analyzing AstraZeneca Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
AstraZeneca PLC Predictive Forecast Models
AstraZeneca PLC's time-series forecasting models is one of many AstraZeneca PLC's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AstraZeneca PLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about AstraZeneca PLC
Checking the ongoing alerts about AstraZeneca PLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AstraZeneca PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company has accumulated 22.96 B in total debt with debt to equity ratio (D/E) of 0.87, which is about average as compared to similar companies. AstraZeneca PLC has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AstraZeneca PLC until it has trouble settling it off, either with new capital or with free cash flow. So, AstraZeneca PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AstraZeneca PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AstraZeneca to invest in growth at high rates of return. When we think about AstraZeneca PLC's use of debt, we should always consider it together with cash and equity. |
Check out AstraZeneca PLC Backtesting, AstraZeneca PLC Valuation, AstraZeneca PLC Correlation, AstraZeneca PLC Hype Analysis, AstraZeneca PLC Volatility, AstraZeneca PLC History as well as AstraZeneca PLC Performance. Note that the AstraZeneca PLC information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for AstraZeneca Pink Sheet analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |